Influence of caffeine on frequency of hypoglycemia detected by continuous interstitial glucose monitoring system in patients with long-standing type 1 diabetes

Diabetes Care

Volumn 28, Issue 6, 2005, Pages 1316-1320

  Richardson, Tristan ^a   Thomas, Peter ^b   Ryder, Jacqueline ^a   Kerr, David ^b  

^a ROYAL BOURNEMOUTH HOSPITAL   (United Kingdom)

^b POOLE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; LIFE CARD; PLACEBO;

ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; CHOLINERGIC ACTIVITY; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS GLUCOSE MONITORING SYSTEM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DISEASE DURATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; HEART RATE VARIABILITY; HOLTER MONITORING; HUMAN; HYPOGLYCEMIA; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MONITOR; RANDOMIZED CONTROLLED TRIAL;

ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; DIABETES MELLITUS, TYPE 1; DOUBLE-BLIND METHOD; FEMALE; HEART RATE; HUMANS; HYPOGLYCEMIA; MALE; MIDDLE AGED; MONITORING, AMBULATORY; PLACEBOS;

EID: 19944397493     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.6.1316     Document Type: Article

References (31)

1. Pramming S, Thorsteinsson B, Bendtson I, Binder C: Symptomatic hypoglycemia in 411 type 1 diabetic patients. Diabet Med 8:217-222, 1991
2. Stephenson JM, Kempler P, Perin PC, Fuller JH: Is autonomic neuropathy a risk factor for severe hypoglycaemia? The EURODIAB IDDM Complications Study. Diabetologia 39:1372-1376, 1996
3. Sachedina N, Pickup JC: Performance assessment of the Medtronic-MiniMed Continuous Glucose Monitoring System and its use for measurement of glycaemic control in type 1 diabetic subjects. Diabet Med 20:1012-1015, 2003
4. Amin R, Ross K, Acerini CL, Edge JA, Warner J, Dunger DB: Hypoglycemia prevalence in prepubertal children with type 1 diabetes on standard insulin regimen: use of continuous glucose monitoring system. Diabetes Care 26:662-667, 2003
5. Bode BW, Steed RD, Davidson PC: Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type 1 diabetes. Diabetes Care 19:324-327, 1996
6. Debrah K, Sherwin RS, Murphy J, Kerr D: Effect of caffeine on recognition of and physiological responses to hypoglycemia in insulin-dependent diabetes. Lancet 347:19-24, 1996
7. Richardson T, Rozkovec A, Thomas P, Ryder J, Kerr D: Influence of caffeine on heart rate variability in patients with long-standing type 1 diabetes. Diabetes Care 27:1127-1131, 2004
8. Villareal RP, Liu BC, Massumi A: Heart rate variability and cardiovascular mortality. Curr Atheroscler Rep 4:120-127, 2002
9. Lombardi F, Makikallio TH, Myerburg RJ, Huikuri HV: Sudden cardiac death: role of heart rate variability to identify patients at risk. Cardiovasc Res 50:210-217, 2001
10. Bode BW, Gross TM, Thornton KR: Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study. Diabetes Res 46:183-190, 1999
11. Choudary P, Emery C, Davies C, Malik R, Allen K, Mills K, Richardson T, McLaughlin D, McLaren M, Tilly I, Heller SR. Development of a robust method to identify episodes of clinically relevant hypoglycemia using the MiniMed Medtronic continuous glucose monitoring system. Diabetes Metab 29: 2250-2255A, 2003
12. Fanelli C, Pampanelli S, Epifano L, Rambotti AM, Ciofetta M, Moda F, Di Vincenzo A, Annibale B, Lepore M, Lalli C: Relative roles of insulin and hypoglycemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycemia in male and female humans. Diabetologia 37:797-807, 1994
13. The DCCT Research Group: Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes 46:271-286, 1997
14. The DCCT Research Group: Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial. Am J Med 90:450-459, 1991
15. Kerr D, Sherwin RS, Pavalkis F, Fayad PB, Sikorski L, Rife F, Tamborlane WV, During MJ: Effect of caffeine on the recognition of and responses to hypoglycemia in humans. Ann Intern Med 119:799-804, 1993
16. Watson JM, Jenkins EJ, Hamilton P, Lunt MJ, Kerr D: Influence of caffeine on the frequency and perception of hypoglycemia in free-living patients with type 1 diabetes. Diabetes Care 23:455-459, 2000
17. Heller SR, Cryer PE: Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after1 episode of hypoglycemia in nondiabetic humans. Diabetes 40:223-226, 1991
18. Polinsky RJ, Kopin IJ, Ebert MH, Weise V: The adrenal medullary response to hypoglycemia in patients with orthostatic hypotension. J Clin Endocrinol Metab 51: 1401-1406, 1980
19. Bjork E, Palmer M, Shvarcz E, Berne C: Incidence of severe hypoglycemia in an unselected population of patients with insulin-treated diabetes mellitus, with special reference to autonomic neuropathy. Diabetes Nutr Metab 4:303-309, 1990
20. Ryder RE, Owens DR, Hayes TM, Ghatei MA, Bloom SR: Unawareness of hypoglycemia and inadequate hypoglycemic counterregulation: no causal relation with diabetic autonomic neuropathy. BMJ 301: 783-787, 1990
21. Evans SB, Wilkinson CW, Gronbeck P, Bennett JL, Taborsky GJ Jr, Figlewicz DP: Inactivation of the PVN during hypoglycemia partially simulates hypoglycemia-associated autonomic failure. Am J Physiol Regul Integr Comp Physiol 284:R57-R65, 2003
22. Laurienti PJ, Field AS, Burdette JH, Maldjian JA, Yen YF, Moody DM: Relationship between caffeine-induced changes in resting cerebral perfusion and blood oxygenation level-dependent signal. AJNR Am J Neuroradiol 24:1607-1611, 2003
23. Landolt HP, Werth E, Borbely AA, Dijk DJ: Caffeine intake (200 mg) in the morning affects human sleep and EEG power spectra at night. Brain Res 675:67-74, 1995
24. Jones TW, Porter P, Sherwin RS, Davis EA, O'Leary P, Frazer F, Byrne G, Stick S, Tamborlane WV: Decreased epinephrine responses to hypoglycemia during sleep. N Engl J Med 338:1657-1662, 1998 25.
25. Landolt HP, Dijk DJ, Gaus SE, Borbely AA: Caffeine reduces low-frequency delta activity in the human sleep EEG. Neuropsychopharmacology 12:229-238, 1995
26. Nawrot P, Jordan S, Eastwood J, Rotstein J, Hugenholtz A, Feeley M: Effects of caffeine on human health. Food Addit Contam 20:1-30, 2003
27. Smith A: Effects of caffeine on human behavior. Food Chem Toxicol 40:1243-1255, 2002
28. Cheyne E, Kerr D: Making 'sense' of diabetes: using a continuous glucose sensor in clinical practice. Diabetes Metab Res Rev 18 (Suppl. 1):S43-S48, 2002
29. McGowan K, Thomas W, Moran A: Spurious reporting of nocturnal hypoglycemia by CGMS in patients with tightly controlled type 1 diabetes. Diabetes Care 25:1499-1503, 2002
30. Caplin NJ, O'Leary P, Bulsara M, Davis EA, Jones TW: Subcutaneous glucose sensor values closely parallel blood glucose during insulin-induced hypoglycaemia. Diabet Med 20:238-241, 2003
31. Monsod TP, Flanagan DE, Rife F, Saenz R, Caprio S, Sherwin RS, Tamborlane WV: Do sensor glucose levels accurately predict plasma glucose concentrations during hypoglycemia and hyperinsulinemia? Diabetes Care 25:889-893, 2002